CYP19A1 and disease of the tendon: Moreover, tendon disorders are reportedly associated with the use of statins (Marie et al., 2008), aromatase inhibitors (Laroche et al., 2017; Mitsimponas et al., 2018), and glucocorticoids (Wise et al., 2012).